Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial. | Breast | 2022 | 36206609 | PubTator, text mining | PubMed |
| Screening of ferroptosis-related genes with prognostic effect in colorectal cancer by bioinformatic analysis. | Front Mol Biosci | 2022 | 36203871 | PubTator, text mining | PubMed |
| The antioxidant and oxidant properties of hydropersulfides (RSSH) and polysulfide species. | Redox Biol | 2022 | 36201912 | PubTator, text mining | PubMed |
| Two novel anti-aminoacyl tRNA synthetase antibodies: Autoantibodies against cysteinyl-tRNA synthetase and valyl-tRNA synthetase. | Autoimmun Rev | 2022 | 36191779 | PubTator, text mining | PubMed |
| New insights into CAR T cell-mediated killing of tumor cells. | Front Immunol | 2022 | 36189315 | PubTator, text mining | PubMed |
| Ferroptosis-related gene ATG5 is a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma. | Front Bioeng Biotechnol | 2022 | 36185455 | PubTator, text mining | PubMed |
| CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. | Sci Adv | 2022 | 36179026 | PubTator, text mining | PubMed |
| Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. | Cancer Cell Int | 2022 | 36175889 | PubTator, text mining | PubMed |
| Trogocytosis-mediated tumor relapse after CAR-NK cell therapy prevented by inhibitory CARs. | Nat Med | 2022 | 36175680 | PubTator, text mining | PubMed |
| KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. | Nat Med | 2022 | 36175679 | PubTator, text mining | PubMed |
| Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential. | Cell Mol Life Sci | 2022 | 36173485 | PubTator, text mining | PubMed |
| Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells. | Front Immunol | 2022 | 36172388 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy. | Theranostics | 2022 | 36168626 | PubTator, text mining | PubMed |
| Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness. | Theranostics | 2022 | 36168619 | PubTator, text mining | PubMed |
| Current progress in CAR-T cell therapy for tumor treatment. | Oncol Lett | 2022 | 36168313 | PubTator, text mining | PubMed |
| Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy. | J Transl Med | 2022 | 36167591 | PubTator, text mining | PubMed |
| Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors. | J Immunother Cancer | 2022 | 36167467 | PubTator, text mining | PubMed |
| CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations. | Clin Transl Med | 2022 | 36163632 | PubTator, text mining | PubMed |
| Identification of the genetic central dogma in osteogenic differentiation of MSCs by osteoinductive medium from transcriptional data sets. | Chronic Dis Transl Med | 2022 | 36161200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=55